Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 302

Insightin inspires with $12m series A

The healthcare engagement technology provider has received $12m in a round co-led by the Blue Cross Blue Shield-backed Blue Venture Fund.

Feb 12, 2021

Phable tells of $12m series A

Phable, developer of a chronic disease assistance app, has secured funding in a round led by healthcare provider Manipal Hospitals.

Feb 12, 2021

Autocrypt authorises series A round

Penta Security's V2X security software spinoff received nearly $13m from investors including IBK, Kookmin Bank and Hyundai Venture Investment Corp.

Feb 12, 2021

C-Zero seizes series A cash

The gas-to-hydrogen technology developer bagged $11.5m in a round co-led by Eni Next and backed by Mitsubishi Heavy Industries.

Feb 12, 2021

Plus adds $200m in funding

Wanxiang International Investment co-led a round for the automated trucking system developer that included existing backer Full Truck Alliance.

Feb 11, 2021

Day One progresses to $130m series B

Access Biotechnology returned for a round that will push Day One Biopharmaceuticals' paediatric drug candidate through a phase 2 study.

Feb 11, 2021

Daily deal net: February 11, 2021

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

Feb 11, 2021

RapidSOS rescues $85m in series C round

The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.

Feb 11, 2021

Armis arms itself with $125m

CapitalG took part in a round that valued the cybersecurity software provider at $2bn and came just over a year after it was acquired for $1.1bn.

Feb 11, 2021

PGDx picks up $103m in series C

The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.

Feb 11, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here